During the COVID-19 pandemic, one older inpatient with multiple comorbidities was treated with nivolumab (a PD-1/PD-L1 inhibitor) for metastatic malignant melanoma and was in good condition, and no pneumonia was detected 87. The gene discussed is PDCD1; the disease is susceptibility to pneumonia measurement.